FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd. is the key subsidiary of Jiangsu High Hope International Group, which is "Top 500" company in China. It is mainly engaged in R&D, manufacturing and distribution of APIs and intermediates such as Fosfomycin Trometamol, Fosfomycin Phenethylamine, Fosfomycin calcium, Fosfomycin sodium, Mildronate, L-Theanine, Diethyl iminodiacetate, N-Methylphthalimide etc.
more >
Year of Establishment:
2002
Total Assets(USD):
100,000,000 to 249,999,999
Total Number of Staff:
150 to 199
Main Competitive Advantages:
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Since it was founded, FarmaSino has been approved to engage in R&D, technology transfer, import, export and domestic trade of pharmaceuticals and chemicals. Scientific and quantified Standard Operation Procedure (SOP) has been formed to fit to itself
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
100,000,000 to 249,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Since it was founded, FarmaSino has been approved to engage in R&D, technology transfer, import, export and domestic trade of pharmaceuticals and chemicals. Scientific and quantified Standard Operation Procedure (SOP) has been formed to fit to itself
Patents and Copyrights: